Biogen
BIIB
782 hedge funds and large institutions have $68.4B invested in Biogen in 2014 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 275 increasing their positions, 302 reducing their positions, and 69 closing their positions.
17% more first-time investments, than exits
New positions opened: 81 | Existing positions closed: 69
9% more funds holding in top 10
Funds holding in top 10: 33 → 36 (+3)
4% more capital invested
Capital invested by funds: $66.1B → $68.4B (+$2.35B)
1% more funds holding
Funds holding: 776 → 782 (+6)
9% less repeat investments, than reductions
Existing positions increased: 275 | Existing positions reduced: 302
25% less call options, than puts
Call options by funds: $814M | Put options by funds: $1.09B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$493M |
| 2 |
JP Morgan Chase
New York
|
+$280M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$133M |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$126M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$115M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$253M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$235M |
| 3 |
MCM
Marsico Capital Management
Denver,
Colorado
|
-$168M |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$161M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$126M |
BIIB Hedge Fund Activity: Q2 2014 in Review
782 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q2 2014, worth a combined $68.4B — up 3.6% from $66.1B a quarter earlier.
Buyers outnumbered sellers: 81 funds opened new BIIB positions and 69 closed out — a net gain of 12 holders — while 275 added to existing stakes and 302 trimmed.
The largest buyer was Norges Bank, adding an estimated $493M. The largest seller was Wellington Management Group, cutting an estimated $253M.
- 782 institutional investors held Biogen (BIIB) as of Q2 2014, up from 776 in Q1 2014.
- Funds reported $68.4B of Biogen stock for Q2 2014, up 3.6% quarter-over-quarter.
- 81 funds opened new Biogen positions in Q2 2014 and 69 closed out, a net change of +12 holders.
- The largest Biogen buyer in Q2 2014 was Norges Bank, an estimated $493M added.
- The largest Biogen seller in Q2 2014 was Wellington Management Group, an estimated $253M sold.
Based on aggregated 13F filings for Q2 2014.